Stock Rating Downgrade
The Value Trend Rating for CONMED Corp (NYSE: CNMD) weakened in recent days from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our next report.
Recent Price Action
On 1/10/25, CONMED Corp (NYSE: CNMD) stock rose slightly by 0.09%, closing at $68.82. Moreover, this advance was accompanied by above average trading volume at 126% of normal. The stock has performed in line with the market over the last nine months and has risen 0.6% during the last week.
Current PriceTarget Research Rating
CONMED has a current Value Trend Rating of D (Negative). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. CONMED has a neutral Appreciation Score of 43 and a slightly negative Power Rating of 33, producing the Negative Value Trend Rating.
Be the first to comment